Targeted labeling of an early-stage tumor spheroid in a chorioallantoic membrane model with upconversion nanoparticles

In vivo detection of cancer at an early-stage, i.e. smaller than 2 mm, is a challenge in biomedicine. In this work target labeling of an early-stage tumor spheroid (∼500 μm) is realized for the first time in a chick embryo chorioallantoic membrane (CAM) model with monoclonal antibody functionalized...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Nanoscale 2015-02, Vol.7 (5), p.1596-1600
Hauptverfasser: Liu, Kai, Holz, Jasmin A, Ding, Yadan, Liu, Xiaomin, Zhang, Youlin, Tu, Langping, Kong, Xianggui, Priem, Bram, Nadort, Annemarie, Lambrechts, Saskia A G, Aalders, Maurice C G, Buma, Wybren Jan, Liu, Yichun, Zhang, Hong
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:In vivo detection of cancer at an early-stage, i.e. smaller than 2 mm, is a challenge in biomedicine. In this work target labeling of an early-stage tumor spheroid (∼500 μm) is realized for the first time in a chick embryo chorioallantoic membrane (CAM) model with monoclonal antibody functionalized upconversion nanoparticles (UCNPs-mAb).
ISSN:2040-3364
2040-3372
DOI:10.1039/c4nr05638h